
| WHO Recommended Surveillance Standards (WHO - OMS, 1999, 157 p.) |
|
9GPW: |
WHO Ninth General Programme of Work, 1996-2001 |
|
AAFB: |
Alcohol-acid-fast bacilli |
|
Ab: |
Antibody |
|
AFP: |
Acute flaccid paralysis |
|
AFRO: |
WHO Regional Office for the African Region |
|
Ag: |
Antigen |
|
AIDS: |
Acquired immunodeficiency syndrome |
|
aLRTI: |
Acute lower respiratory tract infections |
|
AMRO: |
see PAHO |
|
ARI: |
Acute respiratory tract infections |
|
BSE: |
Bovine spongiform encephalopathy |
|
CATT: |
Card agglutination trypanosomiasis test |
|
CD4: |
T4 lymphocyte population |
|
CDC: |
Centers for Disease Control and Prevention, Atlanta GA, USA |
|
CJD: |
Creutzfeldt-Jakob disease |
|
CMFL |
Community microfilarial load |
|
CSF: |
Cerebrospinal fluid |
|
DA: |
Direct agglutination test |
|
DEC: |
Diethylcarbamazine |
|
DFA: |
Direct fluorescent antibody |
|
DHF: |
Dengue haemorrhagic fever |
|
DPT: |
Diphtheria, pertussis, tetanus |
|
DSS: |
Dengue shock syndrome |
|
DT: |
Diphtheria, tetanus |
|
EEG: |
Electroencephalogram |
|
EIA: |
Enzyme immunoassay |
|
ELISA: |
Enzyme-linked immunosorbent assay |
|
EMRO: |
WHO Regional Office for the Eastern Mediterranean |
|
EPIET: |
European Programme for Intervention Epidemiology Training |
|
EURO: |
WHO Regional Office for the European Region |
|
FAT: |
Fluorescent antibody test |
|
FETP: |
Field Epidemiology Training Programme |
|
FFI: |
Fatal familial insomnia |
|
FluNet: |
Influenza network |
|
FTA: |
Fluorescent treponemal antibody-absorption |
|
GIS |
Geographic Information System |
|
GPS: |
Global Positioning System |
|
GSS: |
Gerstmann-Sträussler-Scheinker (syndrome) |
|
HAV: |
Hepatitis A virus |
|
HBcAg |
Hepatitis B core antigen |
|
HbeAg: |
Hepatitis B envelope antigen |
|
HbsAg: |
Hepatitis B surface antigen |
|
HBV: |
Hepatitis B virus |
|
HCV: |
Hepatitis C virus |
|
HDV: |
Hepatitis D virus |
|
HepB3: |
hepatitis B vaccine |
|
HEV: |
Hepatitis E virus |
|
HI |
Haemagglutination inhibition (test) |
|
Hib. |
Haemophilus influenzae type b |
|
HIV: |
Human immunodeficiency virus |
|
HTP: |
Hydroxytryptophane |
|
IARC: |
International Agency for Research in Cancer, WHO, Lyon, France |
|
ICD-10: |
International Classification of Diseases, 10th revision, WHO |
|
ID: |
Identification |
|
IF: |
Indirect Immunofluorescence |
|
IFA: |
Immunofluorescent assay |
|
IFAT: |
Indirect immunoflourescent antibody test |
|
IgG |
Immunoglobulin G |
|
IgM |
Immunoglobulin M |
|
IGO |
Intergovernmental organization |
|
IHR |
International Health Regulations |
|
IP |
Immunoperoxidase |
|
JE: |
Japanese encephalitis |
|
MAT: |
Microscopic Agglutination Test |
|
MDT: |
Multidrug therapy |
|
MNH: |
Programme on Mental Health, WHO |
|
MoH: |
Ministry of Health |
|
NGO: |
Nongovernmental organization |
|
NPEV: |
Non-poliomyelitis enterovirus |
|
nvCJD: |
New variant Creutzfeldt-Jakob disease |
|
OPV: |
Oral poliomyelitis vaccine |
|
PAB: |
Protected at Birth |
|
PAHO: |
Pan-American Health Organization |
|
PAS: |
Periodic acid-Schiff (stain) |
|
PCR: |
Polymerase chain reaction |
|
PrP: |
Protease-prion protein |
|
RPR: |
Rapid Plasma Reagin |
|
SEARO: |
WHO Regional Office for South-East Asia |
|
SRL: |
Supra-national reference laboratory |
|
STD: |
Sexually transmitted diseases |
|
Td: |
Tetanus-diphtheria [toxoid] |
|
TEPHINET: |
Training in Epidemiology and Public Health Intervention Network |
|
TPHA: |
Treponema pallidum haemagglutination antibodies |
|
TT: |
Tetanus toxoid |
|
UNAIDS: |
Joint United Nations Programme on HIV/AIDS |
|
VDRL: |
Venereal Disease Research Laboratory |
|
WHA: |
World Health Assembly |
|
WHO: |
World Health Organization |
|
WPRO: |
WHO Regional Office for the Western Pacific |